Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $CORT vs $ZTS | Chartloom

Compare

$CORT vs $ZTS

Corcept Therapeutics Inc · Zoetis Inc

CORT

Corcept Therapeutics Inc

ZTS

Zoetis Inc

Compare $CORT vs $ZTS

Comparing Corcept Therapeutics Inc and Zoetis Inc

CORTCorcept Therapeutics Inc

ZTSZoetis Inc

CORTCorcept Therapeutics Inc

Market cap

$12.73B

P/E (TTM)

252.72x

Forward P/E (NTM)

28.94x

Forward P/S (NTM)

8.27x

Rev growth (TTM)

16.0%

YTD performance

208.4%

52W performance

59.3%

FCF yield

0.8%

ZTSZoetis Inc

Market cap

$31.15B

P/E (TTM)

11.86x

Forward P/E (NTM)

11.87x

Forward P/S (NTM)

3.33x

Rev growth (TTM)

1.4%

YTD performance

-41.0%

52W performance

-47.3%

FCF yield

7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CORT

ZTS

Detailed metrics comparison

CORT

Corcept Therapeutics Inc

ZTS

Zoetis Inc

Market Cap

CORT$12.73B

ZTS$31.15B

Enterprise Value

CORT$12.62B

ZTS$38.72B

Price

CORT$117.80

ZTS$74.30

P/E Ratio

CORT252.72x

ZTS11.86x

P/S Ratio

CORT15.33x

ZTS3.27x

EV/Sales

CORT15.19x

ZTS4.07x

EV/EBITDA

CORT1,442.80x

ZTS9.35x

P/B Ratio

CORT18.56x

ZTS9.77x

P/FCF Ratio

CORT119.10x

ZTS13.17x

EV/FCF

CORT118.06x

ZTS16.37x

PEG Ratio

CORTN/A

ZTS2.09x

Forward P/E (NTM)

CORT28.94x

ZTS11.87x

Forward P/S (NTM)

CORT8.27x

ZTS3.33x

Revenue (TTM)

CORT$831M

ZTS$9.52B

Revenue Growth (YoY)

CORT16.0%

ZTS1.4%

Forward Rev Growth

CORT48.8%

ZTS1.3%

Gross Margin (TTM)

CORT98.3%

ZTS71.6%

Operating Margin (TTM)

CORT0.8%

ZTS34.4%

EBITDA Margin (TTM)

CORT1.0%

ZTS43.3%

Net Margin (TTM)

CORT6.6%

ZTS27.5%

FCF Margin (TTM)

CORT12.9%

ZTS24.9%

Net Income (TTM)

CORT$55M

ZTS$2.62B

FCF (TTM)

CORT$107M

ZTS$2.37B

EPS (TTM)

CORT$0.47

ZTS$6.26

ROE (TTM)

CORT8.4%

ZTS69.3%

ROA (TTM)

CORT6.6%

ZTS17.2%

ROIC (TTM)

CORT8.4%

ZTS21.2%

Cash

CORT$111M

ZTS$1.47B

Debt

CORT$0

ZTS$9.05B

Net Cash/Debt

CORT$111M

ZTS$-7.58B

Current Ratio (TTM)

CORT2.86x

ZTS3.08x

Quick Ratio (TTM)

CORT2.63x

ZTS1.84x

Debt/Equity (TTM)

CORT0.00x

ZTS2.87x

Debt/Assets (TTM)

CORT0.0%

ZTS0.0%

Interest Coverage (TTM)

CORTN/A

ZTSN/A

Net Debt/EBITDA (TTM)

CORT0.00x

ZTS0.00x

Beta

CORT0.52

ZTS0.72

52W Performance

CORT59.3%

ZTS-47.3%

YTD Performance

CORT208.4%

ZTS-41.0%

% from 52W High

CORT-6.8%

ZTS-49.9%

% from 52W Low

CORT311.0%

ZTS8.0%

Asset Turnover (TTM)

CORT0.99x

ZTS0.63x

FCF Yield (TTM)

CORT0.8%

ZTS7.6%

Earnings Yield (TTM)

CORT0.4%

ZTS8.4%

Dividend Yield (TTM)

CORTN/A

ZTS2.9%

Rule of 40

CORT28.9

ZTS26.3

EV/GP/RG

CORT0.18

ZTS4.20

Ticker research

View CORT research View ZTS research

Metric	CORT Corcept Therapeutics Inc	ZTS Zoetis Inc
Market & Valuation
Market Cap	$12.73B	$31.15B
Enterprise Value	$12.62B	$38.72B
Price	$117.80	$74.30
P/E Ratio	252.72x	11.86x
P/S Ratio	15.33x	3.27x
EV/Sales	15.19x	4.07x
EV/EBITDA	1,442.80x	9.35x
P/B Ratio	18.56x	9.77x
P/FCF Ratio	119.10x	13.17x
EV/FCF	118.06x	16.37x
PEG Ratio	N/A	2.09x
Forward P/E (NTM)	28.94x	11.87x
Forward P/S (NTM)	8.27x	3.33x
Revenue & Growth
Revenue (TTM)	$831M	$9.52B
Revenue Growth (YoY)	16.0%	1.4%
Forward Rev Growth	48.8%	1.3%
Profitability
Gross Margin (TTM)	98.3%	71.6%
Operating Margin (TTM)	0.8%	34.4%
EBITDA Margin (TTM)	1.0%	43.3%
Net Margin (TTM)	6.6%	27.5%
FCF Margin (TTM)	12.9%	24.9%
Net Income (TTM)	$55M	$2.62B
FCF (TTM)	$107M	$2.37B
EPS (TTM)	$0.47	$6.26
ROE (TTM)	8.4%	69.3%
ROA (TTM)	6.6%	17.2%
ROIC (TTM)	8.4%	21.2%
Financial Health
Cash	$111M	$1.47B
Debt	$0	$9.05B
Net Cash/Debt	$111M	$-7.58B
Current Ratio (TTM)	2.86x	3.08x
Quick Ratio (TTM)	2.63x	1.84x
Debt/Equity (TTM)	0.00x	2.87x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	0.72
52W Performance	59.3%	-47.3%
YTD Performance	208.4%	-41.0%
% from 52W High	-6.8%	-49.9%
% from 52W Low	311.0%	8.0%
Efficiency & Yields
Asset Turnover (TTM)	0.99x	0.63x
FCF Yield (TTM)	0.8%	7.6%
Earnings Yield (TTM)	0.4%	8.4%
Dividend Yield (TTM)	N/A	2.9%
Other
Rule of 40	28.9	26.3
EV/GP/RG	0.18	4.20
Ticker research	View CORT research	View ZTS research

Valuation

P/E Ratio

ZTS

11.86x

CORT

252.72x

P/S Ratio

ZTS

3.27x

CORT

15.33x

EV/FCF

ZTS

16.37x

CORT

118.06x

Growth & revenue

Revenue Growth TTM

CORT

16.0%

ZTS

1.4%

Forward Revenue Growth

CORT

48.8%

ZTS

1.3%

Profitability & performance

Gross Margin

CORT

98.3%

ZTS

71.6%

ROE

ZTS

69.3%

CORT

8.4%

FCF Yield %

ZTS

7.6%

CORT

0.8%

52-Week Performance

CORT

59.3%

ZTS

-47.3%

Detailed metrics comparison

CORT

Corcept Therapeutics Inc

ZTS

Zoetis Inc

Market Cap

CORT$12.73B

ZTS$31.15B

Enterprise Value

CORT$12.62B

ZTS$38.72B

Price

CORT$117.80

ZTS$74.30

P/E Ratio

CORT252.72x

ZTS11.86x

P/S Ratio

CORT15.33x

ZTS3.27x

EV/Sales

CORT15.19x

ZTS4.07x

EV/EBITDA

CORT1,442.80x

ZTS9.35x

P/B Ratio

CORT18.56x

ZTS9.77x

P/FCF Ratio

CORT119.10x

ZTS13.17x

EV/FCF

CORT118.06x

ZTS16.37x

PEG Ratio

CORTN/A

ZTS2.09x

Forward P/E (NTM)

CORT28.94x

ZTS11.87x

Forward P/S (NTM)

CORT8.27x

ZTS3.33x

Revenue (TTM)

CORT$831M

ZTS$9.52B

Revenue Growth (YoY)

CORT16.0%

ZTS1.4%

Forward Rev Growth

CORT48.8%

ZTS1.3%

Gross Margin (TTM)

CORT98.3%

ZTS71.6%

Operating Margin (TTM)

CORT0.8%

ZTS34.4%

EBITDA Margin (TTM)

CORT1.0%

ZTS43.3%

Net Margin (TTM)

CORT6.6%

ZTS27.5%

FCF Margin (TTM)

CORT12.9%

ZTS24.9%

Net Income (TTM)

CORT$55M

ZTS$2.62B

FCF (TTM)

CORT$107M

ZTS$2.37B

EPS (TTM)

CORT$0.47

ZTS$6.26

ROE (TTM)

CORT8.4%

ZTS69.3%

ROA (TTM)

CORT6.6%

ZTS17.2%

ROIC (TTM)

CORT8.4%

ZTS21.2%

Cash

CORT$111M

ZTS$1.47B

Debt

CORT$0

ZTS$9.05B

Net Cash/Debt

CORT$111M

ZTS$-7.58B

Current Ratio (TTM)

CORT2.86x

ZTS3.08x

Quick Ratio (TTM)

CORT2.63x

ZTS1.84x

Debt/Equity (TTM)

CORT0.00x

ZTS2.87x

Debt/Assets (TTM)

CORT0.0%

ZTS0.0%

Interest Coverage (TTM)

CORTN/A

ZTSN/A

Net Debt/EBITDA (TTM)

CORT0.00x

ZTS0.00x

Beta

CORT0.52

ZTS0.72

52W Performance

CORT59.3%

ZTS-47.3%

YTD Performance

CORT208.4%

ZTS-41.0%

% from 52W High

CORT-6.8%

ZTS-49.9%

% from 52W Low

CORT311.0%

ZTS8.0%

Asset Turnover (TTM)

CORT0.99x

ZTS0.63x

FCF Yield (TTM)

CORT0.8%

ZTS7.6%

Earnings Yield (TTM)

CORT0.4%

ZTS8.4%

Dividend Yield (TTM)

CORTN/A

ZTS2.9%

Rule of 40

CORT28.9

ZTS26.3

EV/GP/RG

CORT0.18

ZTS4.20

Ticker research

View CORT research View ZTS research

Metric	CORT Corcept Therapeutics Inc	ZTS Zoetis Inc
Market & Valuation
Market Cap	$12.73B	$31.15B
Enterprise Value	$12.62B	$38.72B
Price	$117.80	$74.30
P/E Ratio	252.72x	11.86x
P/S Ratio	15.33x	3.27x
EV/Sales	15.19x	4.07x
EV/EBITDA	1,442.80x	9.35x
P/B Ratio	18.56x	9.77x
P/FCF Ratio	119.10x	13.17x
EV/FCF	118.06x	16.37x
PEG Ratio	N/A	2.09x
Forward P/E (NTM)	28.94x	11.87x
Forward P/S (NTM)	8.27x	3.33x
Revenue & Growth
Revenue (TTM)	$831M	$9.52B
Revenue Growth (YoY)	16.0%	1.4%
Forward Rev Growth	48.8%	1.3%
Profitability
Gross Margin (TTM)	98.3%	71.6%
Operating Margin (TTM)	0.8%	34.4%
EBITDA Margin (TTM)	1.0%	43.3%
Net Margin (TTM)	6.6%	27.5%
FCF Margin (TTM)	12.9%	24.9%
Net Income (TTM)	$55M	$2.62B
FCF (TTM)	$107M	$2.37B
EPS (TTM)	$0.47	$6.26
ROE (TTM)	8.4%	69.3%
ROA (TTM)	6.6%	17.2%
ROIC (TTM)	8.4%	21.2%
Financial Health
Cash	$111M	$1.47B
Debt	$0	$9.05B
Net Cash/Debt	$111M	$-7.58B
Current Ratio (TTM)	2.86x	3.08x
Quick Ratio (TTM)	2.63x	1.84x
Debt/Equity (TTM)	0.00x	2.87x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	0.72
52W Performance	59.3%	-47.3%
YTD Performance	208.4%	-41.0%
% from 52W High	-6.8%	-49.9%
% from 52W Low	311.0%	8.0%
Efficiency & Yields
Asset Turnover (TTM)	0.99x	0.63x
FCF Yield (TTM)	0.8%	7.6%
Earnings Yield (TTM)	0.4%	8.4%
Dividend Yield (TTM)	N/A	2.9%
Other
Rule of 40	28.9	26.3
EV/GP/RG	0.18	4.20
Ticker research	View CORT research	View ZTS research